Axovant Sciences Ltd. (AXON) Tops Q2 EPS by 12c

Axovant Sciences Ltd. (NYSE: AXON) reported Q2 EPS of ($0.12), $0.12 better than the analyst estimate of ($0.24).

For earnings history and earnings-related data on Axovant Sciences Ltd. (AXON) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Workhorse Group (WKHS) Misses Q2 EPS by 77c
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c